U.S. DNA Manufacturing Market (2025 - 2030) Size, Share & Trends Analysis Report By Type (Plasmid DNA, Synthetic DNA), By Grade (GMP & R&D), By Application (Cell & Gene Therapy, Vaccines, Oligonucleotide-based Drugs), By End-use, And Segment Forecasts

Market Segmentation

U.S. DNA Manufacturing Type Outlook (Revenue, USD Million, 2018 - 2030)
- Plasmid DNA
- Synthetic DNA
  - Gene Synthesis
  - Oligonucleotide Synthesis
U.S. DNA Manufacturing Grade Outlook (Revenue, USD Million, 2018 - 2030)
- GMP Grade
- R&D Grade
U.S. DNA Manufacturing Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cell & Gene Therapy
- Vaccines
- Oligonucleotide-based drugs
- Others
U.S. DNA Manufacturing End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical and Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments